Health Canada has authorized Moderna's mRNA influenza vaccine and a combined influenza and COVID-19 vaccine for adults aged 50 and above. Moderna's mRNA flu shot is called mFLUSIVA, and its joint flu and COVID-19 vaccine is named mCOFLU. According to Moderna, Canada is the first nation to grant approval for both mFLUSIVA and mCOFLU.

GlobalNews Canada reports that moderna informed Global News that the new flu shot and combination vaccine will not be included in the 2026-2027 vaccination season. CBC Health reports that moderna also stated to The Canadian Press that these vaccines will not be available in pharmacies for this year's respiratory virus season.